Skip to main content

A novel cost-efficient hydroponic technology to grow high value plant roots for nutraceuticals, pharmaceuticals & cosmetics

Project description

New technology for growing medical plants

An estimated 18 000 plants known to science are classified as medical plants. However, only 150 of them are industrially farmed. Nutraceutical, pharmaceutical and cosmetic industries obtain the biologically active elements from the plant roots. Nevertheless, production through cultivation or harvesting in the wild, especially for ginseng, do not meet market demands. The EU-funded Rhizomia project is developing an innovative hydroponic technology that enables rapid sustainable production methods. Rhizomia empowers biomass growth and advances active ingredient extraction. Today, the ginseng market is dominated by non-EU actors. Rhizomia aims to create a large-scale production technology that will allow the EU to reach up to 35 % of market share by 2030.

Call for proposal

H2020-EIC-SMEInst-2018-2020

See other projects for this call

Sub call

H2020-SMEInst-2018-2020-2

Coordinator

BOTALYS
Net EU contribution
€ 2 205 000,00
Address
Quai Des Usines 8
7800 Ath
Belgium

See on map

Region
Région wallonne Prov. Hainaut Arr. Ath
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Non-EU contribution
€ 945 000,00